Exagen Diagnostics, Inc. is a discovery driven, patient focused CLIA registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for better management of gastrointestinal, oncological, and other chronic diseases.
Using uniquely powerful discovery technology, Exagen identifies and validates small sets of genomic markers that are used to make practical, meaningful and easily interpreted diagnostic, prognostic and targeted therapy tests for clinical use in our CLIA laboratory, in clinical trials and in pharmaceutical development.
Exagen Diagnostics CLIA # 32D1091237 Laboratory Director: S. Mueller, M.D., Ph.D.
